No longer a confusing amalgam of disciplines, synthetic biology is at the forefront of biotech. In the last decade, the span and expectation of the field has grown rapidly. With applications ranging from medical to environmental, synthetic biology has the potential to revolutionise multiple industries.
According to Global Engage, investment in synthetic biology has been growing exponentially since 2013. A critical point in any field of research is that of commercialisation; when opportunities are abundant. “2017 is set to be the biggest [year] yet” says Global Engage.
Compiled along with investee companies and dates active, the list of 146 synthetic biology investors is available through the following link.
About Global Engage
Global Engage produces conferences for the life sciences, agricultural biotechnology and technology sectors. With their team of researchers and acclaimed speakers, Global Engage meetings enhance the knowledge pool and engage key stakeholders.